Clinical Trials
1
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Serum IGF-II and Cancer: Can IGF II Levels be Used to Monitor and Screen Patients Specifically for Cervical Cancer
- Conditions
- Cervical Intraepithelial Neoplasia IIICervical CancerCervical Intraepithelial Neoplasia II
- First Posted Date
- 2011-06-13
- Last Posted Date
- 2011-06-13
- Lead Sponsor
- Onconix, Inc
- Target Recruit Count
- 60
- Registration Number
- NCT01371695
- Locations
- 🇺🇸
Georgia Health Sciences, Augusta, Georgia, United States
News
No news found